Aashka Hospitals Limited has entered into a Memorandum of Understanding (MoU) on August 7, 2026, to acquire a 70% controlling stake in a newly formed entity comprising four Rhythm Group healthcare businesses. The strategic partnership aims to consolidate Rhythm Medical Stores, Rhythm Multispeciality Hospital, Cardioplus Heart Care, and Rhythm Medical & Heart Hospital into a single corporate structure, giving Aashka majority voting rights and board control.

The move represents a significant expansion for Aashka Hospitals, allowing it to integrate multiple specialty facilities under one umbrella. The company will acquire the 70% equity shares from existing shareholders of the newly emerged entity at a price determined through valuation on the transaction date. No shares are being issued to Aashka Hospitals Limited at this stage; the acquisition involves purchasing existing equity.

The transaction has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also references Securities and Exchange Board of India Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Aashka Hospitals confirmed that there is no primary relationship between the parties prior to this agreement, meaning the transaction does not fall within the definition of related-party transactions.

Key Terms of the Strategic Partnership

Upon completion of the restructuring, the newly emerged company will become a related party to Aashka Hospitals Limited. The MoU grants Aashka the right to appoint directors and restrict changes in the capital structure of the new entity. The agreement does not involve any loan agreements or nominee disclosures that would create potential conflicts of interest.

What This Means for Expansion

By consolidating four distinct healthcare entities into one subsidiary with majority ownership, Aashka Hospitals can streamline operations and leverage synergies across multispecialty services, cardiac care, and medical supplies. The 70% holding ensures decisive control over strategic decisions while potentially allowing minority interests from the original Rhythm Group stakeholders to remain invested. This approach minimizes integration risks compared to a full buyout, as existing management may retain operational roles under the new structure.

The absence of a disclosed monetary value for the agreement suggests the final consideration depends on independent valuations yet to be finalized. Investors should monitor subsequent filings for details on the valuation methodology, timeline for closing, and any regulatory approvals required for the restructuring.

Aashka Hospitals Limited has approved a strategic expansion move by authorizing an investment in a newly proposed subsidiary, Aashka – Rhythm Hospitals Private Limited. The Board of Directors sanctioned the acquisition of a 70% controlling stake in the entity during a meeting held on July 28, 2026, signaling the company's intent to broaden its operational presence in the healthcare sector through dedicated verticals.

The transaction involves a cash consideration of ₹70,000, structured as the subscription of 7,000 equity shares with a face value of ₹10 each. This investment will grant Aashka Hospitals Limited voting rights and control over the proposed subsidiary, which is yet to be incorporated but will be domiciled in India. The move aligns with the company's broader strategy to consolidate and expand its hospital and healthcare activities under distinct corporate structures.

Transaction Details

The financial and structural specifics of the investment are outlined below:

Regulatory Compliance

The approval was formalized in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also adhered to the Securities and Exchange Board of India Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The Board meeting commenced at 17:00 hours and concluded at 18:00 hours on July 28, 2026.

No specific governmental or regulatory approvals are required for the incorporation of the proposed subsidiary. The entity will operate within the existing regulatory framework governing hospitals and healthcare activities in India.

What the Numbers Show

The relatively small monetary value of the investment (₹70,000) reflects the initial incorporation stage of the subsidiary rather than the total capital expenditure required for full-scale operations. The 70% ownership structure indicates that Aashka Hospitals Limited intends to maintain consolidated control while potentially allowing for minority participation or future equity flexibility in the new venture.